High levels of MMP-1 expression in the absence of the 2G single nucleotide polymorphism is mediated by p38 and ERK1/2 mitogen-activated protein kinases in VMM5 melanoma cells

Journal of Cellular Biochemistry

Volumn 86, Issue 2, 2002, Pages 307-319

  Benbow, Ulrike ^a,b   Tower, Grant B ^a   Wyatt, Colby A ^a   Buttice, Giovanna ^a,c   Brinckerhoff, Constance E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c BOSTON UNIVERSITY   (United States)

Author keywords

AP 1; ETS; Gene expression; Invasion; Signal transduction; Transient transfection

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN TYPE 1; DNA; DNA BINDING PROTEIN; FLAVONOID; IMIDAZOLE DERIVATIVE; INTERSTITIAL COLLAGENASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; TRANSCRIPTION FACTOR; UROKINASE; CIS ACTING ELEMENT; COLLAGEN TYPE 3; GUANINE; MITOGEN ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN;

ARTICLE; CANCER INVASION; CELL CULTURE; DRUG ANTAGONISM; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MELANOMA; METABOLISM; PROMOTER REGION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; AMINO ACID SUBSTITUTION; BINDING SITE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FIBROBLAST; GENE DELETION; GENE EXPRESSION; GENE INSERTION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

COLLAGEN TYPE I; DNA; DNA-BINDING PROTEINS; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMIDAZOLES; MATRIX METALLOPROTEINASE 1; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PYRIDINES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR; FLAVONES; INTERSTITIAL COLLAGENASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

INSERTION SEQUENCES;

EID: 0035986312     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10225     Document Type: Article

References (52)

1. Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implications
2. Human breast cancer cells activate procollagenase-1 and invade type I collagen: Invasion is inhibited by all-trans retinoic acid
3. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen
4. Confocal assay for invasion: Use of propidium iodide fluorescence and laser reflectance to quantify the rate of migration of cells through a matrix
5. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases
6. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes
7. Independent role of p38 and ERK1/2 mitogen-activated kinases in the upregulation of matrix metalloproteinase-1
8. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma
9. Interstitial collagenases as markers of tumor progression
10. Novel phorbol ester response region in the collagenase promoter binds Fos and Jun
11. Changing views of the role of matrix metalloproteinases in metastasis
12. Matrix metalloproteinases in tumour invasion and metastasis
13. A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum
14. Organization and regulation of mitogen-activated protein kinase signaling pathways
15. Matrix Metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness
16. Expression of cets-1 mRNA is associated with an invasive. EMT-derived phenotype in breast carcinoma cell lines
17. Cancer statistics, 2000
18. Therapeutic intervention and signaling
19. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
20. Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma
21. Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha 2a
22. Matrix metalloproteinase-1 expression is a prognostic factor for patients with advanced gastric cancer
23. Expression of the MMP-1 in human pancreatic carcinoma: Relationship with prognostic factor
24. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/ deletion polymorphism in its promoter region
25. Unraveling the role of proteases in cancer
26. Signal transduction through MAP kinase cascades
27. The microenvironment of the tumour-host interface
28. Matrix metalloproteinases: Multifunctional contributors to tumor progression
29. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: Differential regulation of collagenase 1 and collagenase 3
30. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer
31. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer
32. Matrix metalloproteinases
33. Matrix metalloproteinases: Biologic activity and clinical implications
34. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas
35. Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter
36. Matrix metalloproteinases
37. The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
38. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription
39. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: A possible mechanism of basement membrane and integrin alterations
40. Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis)
41. ERK1/2 differentially regulates the expression from the 1G/2G single nucleotide polymorphism in the MMP-1 promoter in melanoma cells
42. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis
43. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis
44. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): Mechanisms that control enzyme activity, transcription, and mRNA stability
45. Regulation of matrix metalloproteinase expression in tumor invasion
46. Enhancement of fibroblast collagenase-1 (MMP-1) gene expression by tumor promoter okadaic acid is mediated by stress-activated protein kinases Jun N-terminal kinase and p38
47. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2
48. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression
49. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-fos, and Fra-2
50. Comparison of human stromelysin and collagenase by cloning and sequence analysis
51. Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism
52. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility